- http://twitter.com/OncologyAdvance
- http://www.facebook.com/OncologyAdvance
- http://www.elsevier.com/journals/european-journal-of-cancer/0959-8049/open-access-options
- https://www.researcheracademy.com
- http://ees.elsevier.com/ejc/
- http://www.elsmediakits.com/journal_home/details/EJC
- http://www.eortc.be/
- http://www.eusoma.org/
- http://www.practiceupdate.com
- http://www.journals.elsevierhealth.com/periodicals/home
- http://www.elsevierhealth.com
- http://journalinsights.elsevier.com/journals/0959-8049
- https://www.elsevier.com/journals/european-journal-of-cancer/0959-8049/open-access-options
- http://www.elsevier.com
- http://www.eortc.be
- http://www.ejcancer.com/pb/assets/raw/Health%20Advance/journals/ejc/Richard_Marais.mp3
- http://www.ejcancer.com/pb/assets/raw/Health%20Advance/journals/ejc/Eric_Lim_-_HS.mp3
- http://www.ejcancer.com/pb/assets/raw/Health%20Advance/journals/ejc/Yolande-Lievens.mp3
- http://www.ejcancer.com/pb/assets/raw/Health%20Advance/journals/ejc/EJC-HS-Simon-Pernot.mp3
- http://www.ejcancer.com/pb/assets/raw/Health%20Advance/journals/ejc/EJC_podcast_-_Charles_Ferte_-_HS.mp3
- https://doi.org/10.1016/j.ejca.2019.04.035
- https://doi.org/10.1016/j.ejca.2019.05.024
- https://doi.org/10.1016/j.ejca.2019.04.019
- https://doi.org/10.1016/j.ejca.2019.06.004
- https://doi.org/10.1016/j.ejca.2019.04.012
- https://doi.org/10.1016/j.ejca.2019.05.027
- https://doi.org/10.1016/j.ejca.2019.05.026
- https://doi.org/10.1016/j.ejca.2019.05.004
- https://doi.org/10.1016/j.ejca.2019.06.002
- https://doi.org/10.1016/j.ejca.2019.05.030
- https://doi.org/10.1016/j.ejca.2018.07.005
- https://doi.org/10.1016/j.ejca.2019.04.001
- http://www.sciencedirect.com/science/journal/09598049
- https://www.journals.elsevier.com/european-journal-of-cancer/top-articles/
- https://www.elsevier.com/
- https://www.elsevier.com
- https://www.elsevier.com/legal/privacy-policy
- https://www.elsevier.com/legal/elsevier-website-terms-and-conditions
- https://healthadvance.com/use-of-cookies
- https://www.elsevier.com/wps/find/intro.cws_home/ataglance
- https://www.healthadvance.com/accessibility
- https://www.relx.com/
No comments:
Post a Comment